|本期目录/Table of Contents|

[1]陆林祥,方 军,张飞龙,等.导管射频消融联合左心耳封堵治疗持续性心房颤动1例[J].福建医科大学学报,2016,50(03):181-185.
 LU Linxiang,FANG Jun,ZHANG Feilong,et al.Catheter Radiofrequency Ablation in Combination with Left Atrial AppendageClosure for Persistent Atrial Fibrillation( one case report)[J].Journal of Fujian Medical University,2016,50(03):181-185.
点击复制

导管射频消融联合左心耳封堵治疗持续性心房颤动1例(PDF)
分享到:

《福建医科大学学报》[ISSN:1672-4194/CN:35-1192/R]

卷:
第50卷
期数:
2016年03期
页码:
181-185
栏目:
临床研究
出版日期:
2016-06-29

文章信息/Info

Title:
Catheter Radiofrequency Ablation in Combination with Left Atrial AppendageClosure for Persistent Atrial Fibrillation( one case report)
文章编号:
1672-4194(2016)03-0181-05
作者:
陆林祥 方 军 张飞龙 陈建华 陈学海陈良龙
福建医科大学 附属协和医院心内科,福建省冠心病研究所,福州 350001
Author(s):
LU Linxiang FANG Jun ZHANG Feilong CHEN Jianhua CHEN Xuehai CHEN Lianglong
Fujian Medical University Union Hospital, Fujian Institue of Coronary Disease, Fuzhou 350001,China
关键词:
导管消融术 心房 心房颤动 出血 血栓栓塞 手术后期间
Keywords:
catheter ablation heart atria atrial fibrillation hemorrhage thromboembolism postoperative period
分类号:
R322.11; R540.46
DOI:
-
文献标志码:
A
摘要:
目的 探讨导管射频消融联合左心耳封堵治疗持续性心房颤动的可行性及安全性。 方法 对1例血栓栓塞及出血风险都很高、存在心悸及气促症状的长程持续性心房颤动患者实施导管射频消融后立即进行左心耳封堵,观察手术即刻效果、并发症,术后华法林抗凝45 d,改为阿司匹林、氯吡格雷双联抗血小板,随访3月,观察症状改善情况、出血及血栓事件。 结果 成功同期实施导管射频消融联合左心耳封堵术,术中无心包填塞等并发症,术后随访未发作心悸、气促,左心耳封堵器未见血栓及残余分流,双联抗血小板期间出现牙龈出血,停用阿司匹林后未再出血。 结论 对符合适应证的持续性心房颤动患者实施导管射频消融联合左心耳封堵治疗是可行及安全的。
Abstract:
Objective To investigate the feasibility and safety of radiofrequency catheter ablation combined with left atrial appendage occlusion for the treatment of persistent atrial fibrillation. Methods A persistent atrial fibrillation patient with high risk of thromboembolism and bleeding, suffering from palpitations and short breath, underwent left atrial appendage closure following radiofrequency catheter ablation, and the outcomes and complications were observed. After the procedure, anticoagulation with warfarin was given for 45 days followed by dual antiplatelet therapy with aspirin and clopidogrel. The patient was followed-up for 3 months to observe the improvement of symptoms, bleeding and thrombotic events. Results We succeeded in the implementation of catheter radiofrequency catheter ablation combined with left atrial appendage occlusion. No pericardial effusion or other intraoperative complications were observed. During the follow-up, the patient presented no palpitations, short breath, left atrial appendage occluder thrombus, or residual shunt. Gingival bleeding occured during dual antiplatelet therapy and was stopped when aspirin discontinued. Conclusion It is feasible and safe for patients with persistent atrial fibrillation to receive the combinational therapy of radiofrequency catheter ablation and left atrial appendage occlusion when there are interventional indications.

参考文献/References:

[1] Tilz R R,Rillig A,Thum A M,et al. Catheter ablation of long-standing persistent atrial fibrillation: 5-year outcomes of the Hamburg Sequential Ablation Strategy[J]. J Am Coll Cardiol, 2012,60(19):1921-1929.
[2] Mcbride R. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation:stroke prevention in atrial fibrillation Ⅱ study[J]. Lancet, 1994,343(8899):687-691.
[3] Comes T,Mamdani M M,Holbrook A M,et al. Rates ofhemorrhage during warfarin therapy for atrial fibrillation[J]. CMAJ, 2013,185:E121-127.
[4] Reddy V Y, Doshi S K,Sievert H, et al. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF(watchman left atrial appendage system for embolic protection in patients with atrial fibrillation)trial[J]. Circulation, 2013,127(6):720-729.
[5] Villani G Q,Piepoli P E,VilIani P E,et al. Anticoagulationin atrial fibrillation: what is certain and what is to come[J]. Eur Hcart J, 2003(Suppl):45-50.
[6] Odell J A,Blackshear J L,Davies E,et al. Thoracoscopic obliteration of the left atrial appendage: potential for stroke reduction[J]? Ann Thorac Surg, 1996,61:565-569.
[7] Reddy V Y,M?bius-Winkler S,Miller M A, et al. Left atrial appendage closure with the watchman device in patients with a contraindication for oral anticoagulation: the ASAP study(ASA plavix feasibility study with watchman left atrial appendage closure technology)[J]. J Am Coll Cardiol, 2013,61(25):2551-2556.
[8] Holmes D R,Kar S,Price M J,et al. Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial[J]. J Am Coll Cardio, 2014,64(1):1-12.
[9] Reddy V Y,Sievert H,Halperin J,et al. PROTECT AF steering committee and investigators. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial[J]. JAMA, 2014,312(19):1988-1998.
[10] Camm A J,Lip G Y,De Caterina R,et al. ESC committee for practice guidelines(CPG). 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association[J]. Eur Heart J, 2012,33(21):2719-2747.
[11] Meier B,Blaauw Y,Khattab A A,et al. Document reviewers. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion[J]. Europace, 2014,16(10):1397-1416.
[12] 中华医学会心电生理和起搏分会,中华医学会心血管病学分会,中国医师协会心律学专业委员会. 左心耳干预预防心房颤动患者血栓栓塞事件:目前的认识和建议[J]. 中国心脏起搏与心电生理杂志, 2014(6):471-486.
[13] 黄从新,张 澍,黄德嘉,等. 代表中华医学会心电生理和起搏分会、中国医师协会心律学专业委员会心房颤动防治专家工作委员会. 心房颤动:目前的认识和治疗建议—2015[J]. 中华心律失常学杂志, 2015,19(5):321-384.
[14] January C T,Wann L S,Alpert J S, et al. ACC/AHA task force members. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society[J]. Circulation, 2014,130(23):2071-2104.
[15] Calkins H, Kuck K H, Cappato R, et al. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design[J]. Europace, 2012,14(4):528-606.
[16] Swaans M J,Post M C,Rensing B J, et al. Ablation for atrial fibrillation in combination with left atrial appendage closure: first results of a feasibility study[J]. J Am Heart Assoc, 2012,1(5):e002212.
[17] Calvo N,Salterain N,Arguedas H,et al. Combined catheter ablation and left atrial appendage closure as a hybrid procedure for the treatment of atrial fibrillation[J]. Europace, 2015,17(10):1533-1540.
[18] Walker D T,Phillips K P. Left atrial catheter ablation subsequent to Watchman left atrial appendage device implantation: a single centre experience[J]. Europace, 2015,17(9):1402-1406.
[19] 姚 焰,吴灵敏,侯炳波,等. 经皮左心耳封堵术在心房颤动脑卒中高危患者应用初步经验三例[J]. 中华心律失常学杂志, 2013,17(2):154-155.
[20] 张飞龙,陈良龙,陈学海,等. 应用Watchman封堵器经皮封堵左心耳1例[J]. 临床心血管病杂志, 2015,31(3):347-348.

相似文献/References:

[1]周 灵(综述),林金秀(审校).肾动脉去交感神经消融术治疗慢性心力衰竭的研究进展[J].福建医科大学学报,2019,53(03):205.

备注/Memo

备注/Memo:
收稿日期: 2016-02-03
基金项目: 福建省医学创新课题资助计划(2014-CX-12)
作者单位: 福建医科大学 附属协和医院心内科,福建省冠心病研究所,福州 350001
作者简介: 陆林祥(1968-),男,主任医师,医学硕士
通讯作者: 陈良龙. Email:lianglongchen@126.com
更新日期/Last Update: 2016-09-01